Read Time:7 Second
The results come amid the rollout of Biogen and Eisai’s Leqembi, the first drug found to slow the progression of Alzheimer’s to win FDA approval.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
